Target intelligence / Profile preview

Glucose metabolism regulation pathway

Molecular classification
Other
01

Overview

The glucose metabolism regulation pathway encompasses a complex system of biological processes and regulatory controls that maintain blood glucose levels and provide energy to tissues. This system includes the absorption, transport, storage, and utilization of glucose through interconnected pathways such as glycolysis (breakdown of glucose), gluconeogenesis (formation of glucose), glycogenesis (storage as glycogen), and glycogenolysis (mobilization of glycogen)[7][5][3][4]. Regulation is achieved through acute and chronic mechanisms, including the control of enzyme activity by hormones (mainly insulin and glucagon), allosteric effectors, post-translational modifications, and transcriptional regulation via transcription factors (such as CREB, FOXO1, and ChREBP)[1][6][4]. Disruption of this regulation is central to the development of metabolic diseases, including diabetes and obesity. The pathway itself is not a single druggable target, but rather a collection of interacting molecules, each of which can serve as a therapeutic target in metabolic disease[7]. Key point: "Glucose metabolism regulation pathway" refers to a regulatory network or group of interconnected pathways, not to a discrete molecule, protein, or canonical drug target, so it does not meet the criteria for a canonical therapeutic target or molecular entity[7][3][4][1].

Other names
Glucose homeostasis pathwayRegulation of glucose metabolism
02

Mechanism of action

Stimulate or inhibit insulin signaling; Enhance or suppress hepatic gluconeogenesis; Increase glucose uptake in peripheral tissues; Inhibit renal glucose reabsorption; Modulate activity of enzymes and transcription factors involved in glucose metabolism

03

Biological functions

Regulation of cellular energySignal transductionCell proliferationCell survivalGlycolysisGluconeogenesisGlycogenesisGlycogenolysis
04

Disease associations

Diabetes mellitusInsulin resistanceObesityMetabolic syndromeCardiovascular diseaseCancer
05

Safety considerations

Hypoglycemia (with some anti-diabetic drugs)Lactic acidosis (e.g., with metformin)Weight gain or loss (drug-dependent)Cardiovascular risks (agent-specific)
06

Interacting drugs

Insulin

7 more in the full profile.

07

Biomarkers

Blood glucoseHemoglobin A1CInsulinC-peptideGlucagon

Beyond the preview

Go deeper on Glucose metabolism regulation pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose metabolism regulation pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call